A patient with sputum positive pulmonary tuberculosis is on ATT for the last 5 months but the patient is still positive for AFB in the sputum. This case refers to –
**Core Concept**
Pulmonary tuberculosis (TB) treatment failure is a critical concern, especially when patients continue to test positive for acid-fast bacilli (AFB) in their sputum despite receiving anti-tuberculosis therapy (ATT) for an extended period. The development of drug-resistant TB strains is a significant challenge in TB control.
**Why the Correct Answer is Right**
In this scenario, the patient's persistent positive AFB sputum test after 5 months of ATT suggests that the TB strain is resistant to the first-line drugs being used. Drug-resistant TB can arise due to mutations in the TB bacteria that render them insensitive to the drugs, making the current ATT regimen ineffective. The most common cause of treatment failure in TB is the emergence of rifampicin resistance, which is often associated with multidrug-resistant TB (MDR-TB).
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the scenario describes a case of treatment failure, not treatment interruption. Treatment interruption would imply that the patient stopped taking their medication, which is not the case here.
**Option B:** This option is incorrect because the patient's positive AFB sputum test after 5 months of ATT indicates treatment failure, not treatment completion. Treatment completion would typically be confirmed by two consecutive negative sputum tests after the completion of the full ATT regimen.
**Option C:** This option is incorrect because the scenario does not provide any information about the patient's adherence to the ATT regimen. Adherence issues could be a contributing factor to treatment failure, but the primary concern here is the emergence of drug-resistant TB.
**Option D:** This option is incorrect because the patient's positive AFB sputum test after 5 months of ATT does not necessarily indicate treatment resistance. However, in the context of this question, the correct answer implies that the patient's TB strain is resistant to the first-line drugs.
**Clinical Pearl / High-Yield Fact**
In TB treatment, the development of drug resistance is often associated with inadequate or irregular treatment, and it's crucial to promptly identify and isolate patients with drug-resistant TB to prevent further transmission.
**Correct Answer:** C.